Search research articles
Contact Us
Filters
Showing results (221-230 of 347) with videos related to
Page
of 35
Sort By:
Journal of Cachexia, Sarcopenia and Muscle
|
December 13, 2021
Validation of a proxy-reported SARC-F questionnaire for current and retrospective screening of sarcopenia-related functional impairments
Johannes Maurus, Tobias Terzer, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2007
Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors
Dirk Kienle, Tiemo Katzenberger, German Ott, et al.
Cancer Research
|
March 7, 2014
Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer
Gunnar Steinert, Sebastian Schölch, Thomas Niemietz, et al.
European Journal of Haematology
|
September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients
Sabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Frontiers in Immunology
|
June 8, 2026
Letermovir does not affect long-term polyclonal immune reconstitution after allogeneic hematopoietic stem cell transplantation with ATG-based GvHD prophylaxis
Conrad Weidt, Adela Maria Neagoie, Maral Saadati, et al.
Blood Cancer Journal
|
April 10, 2019
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial
Katja C Weisel, Christof Scheid, Manola Zago, et al.
Human Molecular Genetics
|
August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Daniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Blood
|
February 29, 2020
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria
Christoph R Kimmich, Tobias Terzer, Axel Benner, et al.
Haematologica
|
May 20, 2017
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
Ute Hegenbart, Tilmann Bochtler, Axel Benner, et al.
Experimental and Molecular Pathology
|
July 24, 2021
The coding microsatellite mutation profile of PMS2-deficient colorectal cancer
Sanne W Bajwa-Ten Broeke, Alexej Ballhausen, Aysel Ahadova, et al.
Page
of 35
Search research articles
Search
Showing results (221-230 of 347) with videos related to
Sort By:
Page
of 35
Journal of Cachexia, Sarcopenia and Muscle
|
December 13, 2021
Validation of a proxy-reported SARC-F questionnaire for current and retrospective screening of sarcopenia-related functional impairments
Johannes Maurus, Tobias Terzer, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2007
Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors
Dirk Kienle, Tiemo Katzenberger, German Ott, et al.
Cancer Research
|
March 7, 2014
Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer
Gunnar Steinert, Sebastian Schölch, Thomas Niemietz, et al.
European Journal of Haematology
|
September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients
Sabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Frontiers in Immunology
|
June 8, 2026
Letermovir does not affect long-term polyclonal immune reconstitution after allogeneic hematopoietic stem cell transplantation with ATG-based GvHD prophylaxis
Conrad Weidt, Adela Maria Neagoie, Maral Saadati, et al.
Blood Cancer Journal
|
April 10, 2019
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial
Katja C Weisel, Christof Scheid, Manola Zago, et al.
Human Molecular Genetics
|
August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Daniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Blood
|
February 29, 2020
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria
Christoph R Kimmich, Tobias Terzer, Axel Benner, et al.
Haematologica
|
May 20, 2017
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
Ute Hegenbart, Tilmann Bochtler, Axel Benner, et al.
Experimental and Molecular Pathology
|
July 24, 2021
The coding microsatellite mutation profile of PMS2-deficient colorectal cancer
Sanne W Bajwa-Ten Broeke, Alexej Ballhausen, Aysel Ahadova, et al.
Page
of 35